1. Topical cis-urocanic acid attenuates oedema and erythema in acute and subacute skin inflammation in the mouse
- Author
-
Pekka Taimen, Jarmo Laihia, Lasse Leino, and Harry Kujari
- Subjects
medicine.medical_specialty ,integumentary system ,Erythema ,business.industry ,Inflammation ,Endogeny ,Dermatology ,Cis-Urocanic Acid ,Pharmacology ,medicine.disease ,Tacrolimus ,medicine.anatomical_structure ,medicine ,medicine.symptom ,business ,Infiltration (medical) ,Earlobe ,Hydrocortisone ,medicine.drug - Abstract
Summary Background cis-Urocanic acid (cis-UCA) is an endogenous immunosuppressive molecule of the epidermis. Objectives We investigated the effects of topical cis-UCA creams (2·5% and 5%) in acute and subacute mouse models of skin inflammation. Methods Acute skin irritation was induced by applying dimethyl sulphoxide (DMSO) on the earlobe of CD-1 mice. Topical cis-UCA, hydrocortisone (1%) or tacrolimus (0·1%) were applied 10 min later. In another model, subacute inflammation was provoked and maintained by three applications of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the ears of NMRI mice on days 1, 2 and 4. The test products were applied topically twice a day during 6 days. Results In the acute DMSO model, cis-UCA creams suppressed ear swelling at 1 h significantly more efficiently than hydrocortisone (P
- Published
- 2012
- Full Text
- View/download PDF